Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy
about
A Shorter Route to Antibody Binders via Quantitative in vitro Bead-Display Screening and Consensus Analysis.A promising "TRAIL" of tanshinones for cancer therapy.Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells.Therapeutic applications of TRAIL receptor agonists in cancer and beyond.Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironmentQuinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.Bufalin sensitizes human bladder carcinoma cells to TRAIL-mediated apoptosis.Cancer and necroptosis: friend or foe?Using natural products to promote caspase-8-dependent cancer cell death.Anti-Cancer Phytometabolites Targeting Cancer Stem CellsSynergistic Interplay between Curcumin and Polyphenol-Rich Foods in the Mediterranean Diet: Therapeutic Prospects for Neurofibromatosis 1 Patients.Protective Role for TWEAK/Fn14 in Regulating Acute Intestinal Inflammation and Colitis-Associated Tumorigenesis.Shell effects on acoustic performance of a drug-delivery system activated by ultrasound.MicroRNA-125b-1-3p mediates intervertebral disc degeneration in rats by targeting teashirt zinc finger homeobox 3.Herbal Medicines Showing Synergistic Effects with Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) against A549 TRAIL-resistant Lung Cancer Cells: A Screening Study.Tumor necrosis factor-related apoptosis-inducing ligand additive with Iodine-131 of inhibits non-small cell lung cancer cells through promoting apoptosis.Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells
P2860
Q36183984-1964A32C-E6A5-40B0-A85B-EC74723590FDQ36332681-00BA36EB-A3FB-4F90-AD45-C144BBBFDFBCQ36996317-B79ECACB-0E47-4028-9F4C-552CC2D9C0C2Q37114025-C916556F-2714-4824-93C3-8F8A2F516D2AQ37520325-F1ACEFA2-303B-41EF-8BB5-63AEB1AABF99Q37702210-C7C083D8-E827-4D3C-B353-F4814AB7407DQ38686012-F4059DCB-5062-4BD6-86FC-690BBCAAF663Q38799139-39184095-D31D-4154-8DB9-86EE0DFFDA35Q38861356-1D8AAE6E-FBAE-4BE6-825C-8DD9F0ED773FQ39214227-083D1ADC-916A-4652-A106-45A98713C032Q42340618-7D6AFCEB-9CFF-4C2A-8B49-FE8DDBF7610EQ43238527-75C0438C-392D-4166-853D-FD6198963283Q47328097-0C47061F-C3AC-41AF-8880-1298E8553A90Q49875874-286D8927-0020-4179-A642-D957F32ECE4BQ53688757-AE1B69DE-C480-44C9-894B-E71D70184723Q55240083-08F4CC8A-EB69-4568-8E0D-B2928A8FA0FBQ59134014-309DAC67-919C-488F-94A1-633FC0D4D2E6
P2860
Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 April 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting TNF-related apoptosi ...... ic approach for cancer therapy
@en
Targeting TNF-related apoptosis-inducing ligand
@nl
type
label
Targeting TNF-related apoptosi ...... ic approach for cancer therapy
@en
Targeting TNF-related apoptosis-inducing ligand
@nl
prefLabel
Targeting TNF-related apoptosi ...... ic approach for cancer therapy
@en
Targeting TNF-related apoptosis-inducing ligand
@nl
P2093
P2860
P356
P1476
Targeting TNF-related apoptosi ...... ic approach for cancer therapy
@en
P2093
Alan Prem Kumar
Arunachalam Chinnathambi
Frank Arfuso
Jingwen Zhang
Kwang Seok Ahn
Sulaiman Ali Alharbi
Xiaoyun Dai
P2860
P304
P356
10.1177/1535370215579167
P50
P577
2015-04-07T00:00:00Z